| Peter Pegolo, OD | |
|
612 Quaker Ln S, Suite B, West Hartford, CT 06110-1027 | |
| (860) 236-1218 | |
| (860) 231-9298 |
| Full Name | Peter Pegolo |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 28 Years |
| Location | 612 Quaker Ln S, West Hartford, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184733255 | NPI | - | NPPES |
| 2V5586 | Other | HEALTH NET | |
| 5094583 | Other | AETNA | |
| 002448 | Other | CONNECTICARE | |
| 090002448CT02 | Other | BLUE CROSS BLUE SHIELD | |
| 1749886 | Other | CIGNA | |
| 203912450 | Other | UNITED HEALTH CARE | |
| 203912450 | Other | VISION SERVICE PLAN | |
| 522108187187 | Other | TRICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | CT02448 (Connecticut) | Primary |
| Provider Name | Optometric Specialty Group Limited Liability Company |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1184717365 PECOS PAC ID: 7416955075 Enrollment ID: O20061116000076 |
News Archive
Men worried about prostate cancer have a new online resource, freely available, to help them assess their risk. The multi-step Prostate Cancer Risk Calculator, www.prostatecancer-riskcalculator.com*, has been created by the founders of the European Randomized Study of Screening for Prostate Cancer (ERSPC).
July 3 was the quiet afternoon that a deputy assistant Treasury secretary for tax policy announced in a blog post that the Affordable Care Act's employer mandate would be delayed one year. Something about the "complexity of the requirements." ... Even if you are a liberal and support the goals of the Affordable Care Act, there has to be an emerging sense that maybe the law's theorists missed a signal from life outside the castle walls. While they troweled brick after brick into a 2,000-page law, the rest of the world was reshaping itself into smaller, more nimble units whose defining metaphor is the 140-character Twitter message (Daniel Henninger, 7/10).
Advances in energy conservation, better materials for frontier technologies and new economic engines, and breakthroughs in understanding diseases: These are just a few of the potential discoveries, both basic and applied, to be enabled by an upgrade to the Advanced Photon Source (APS) at the U.S. Department of Energy's (DOE) Argonne National Laboratory. DOE today announced formal approval for conceptual design of the APS upgrade, the first in a series of major milestones that the project must meet under DOE's project management regimen.
Alemtuzumab, an anti-CD52 monoclonal antibody, provides a more effective treatment for individuals with relapsing‑remitting multiple sclerosis than the immunomodulating drug interferon beta 1a, but has significant side effects, show findings from a phase III trial.
Bupa has announced the launch of the first part of its new health section online at bupa-intl.com, featuring more interactive content and 50 medical factsheets for an international audience.
› Verified 7 days ago
| Provider Name | Optometric Specialty Group Of Wethersfield, Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1629561428 PECOS PAC ID: 4183975014 Enrollment ID: O20180917000180 |
News Archive
Men worried about prostate cancer have a new online resource, freely available, to help them assess their risk. The multi-step Prostate Cancer Risk Calculator, www.prostatecancer-riskcalculator.com*, has been created by the founders of the European Randomized Study of Screening for Prostate Cancer (ERSPC).
July 3 was the quiet afternoon that a deputy assistant Treasury secretary for tax policy announced in a blog post that the Affordable Care Act's employer mandate would be delayed one year. Something about the "complexity of the requirements." ... Even if you are a liberal and support the goals of the Affordable Care Act, there has to be an emerging sense that maybe the law's theorists missed a signal from life outside the castle walls. While they troweled brick after brick into a 2,000-page law, the rest of the world was reshaping itself into smaller, more nimble units whose defining metaphor is the 140-character Twitter message (Daniel Henninger, 7/10).
Advances in energy conservation, better materials for frontier technologies and new economic engines, and breakthroughs in understanding diseases: These are just a few of the potential discoveries, both basic and applied, to be enabled by an upgrade to the Advanced Photon Source (APS) at the U.S. Department of Energy's (DOE) Argonne National Laboratory. DOE today announced formal approval for conceptual design of the APS upgrade, the first in a series of major milestones that the project must meet under DOE's project management regimen.
Alemtuzumab, an anti-CD52 monoclonal antibody, provides a more effective treatment for individuals with relapsing‑remitting multiple sclerosis than the immunomodulating drug interferon beta 1a, but has significant side effects, show findings from a phase III trial.
Bupa has announced the launch of the first part of its new health section online at bupa-intl.com, featuring more interactive content and 50 medical factsheets for an international audience.
› Verified 7 days ago
| Provider Name | Optometric Specialty Group Of Simsbury Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1457085722 PECOS PAC ID: 4385014356 Enrollment ID: O20230109001109 |
News Archive
Men worried about prostate cancer have a new online resource, freely available, to help them assess their risk. The multi-step Prostate Cancer Risk Calculator, www.prostatecancer-riskcalculator.com*, has been created by the founders of the European Randomized Study of Screening for Prostate Cancer (ERSPC).
July 3 was the quiet afternoon that a deputy assistant Treasury secretary for tax policy announced in a blog post that the Affordable Care Act's employer mandate would be delayed one year. Something about the "complexity of the requirements." ... Even if you are a liberal and support the goals of the Affordable Care Act, there has to be an emerging sense that maybe the law's theorists missed a signal from life outside the castle walls. While they troweled brick after brick into a 2,000-page law, the rest of the world was reshaping itself into smaller, more nimble units whose defining metaphor is the 140-character Twitter message (Daniel Henninger, 7/10).
Advances in energy conservation, better materials for frontier technologies and new economic engines, and breakthroughs in understanding diseases: These are just a few of the potential discoveries, both basic and applied, to be enabled by an upgrade to the Advanced Photon Source (APS) at the U.S. Department of Energy's (DOE) Argonne National Laboratory. DOE today announced formal approval for conceptual design of the APS upgrade, the first in a series of major milestones that the project must meet under DOE's project management regimen.
Alemtuzumab, an anti-CD52 monoclonal antibody, provides a more effective treatment for individuals with relapsing‑remitting multiple sclerosis than the immunomodulating drug interferon beta 1a, but has significant side effects, show findings from a phase III trial.
Bupa has announced the launch of the first part of its new health section online at bupa-intl.com, featuring more interactive content and 50 medical factsheets for an international audience.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Peter Pegolo, OD 612 Quaker Ln S, Suite B, West Hartford, CT 06110-1027 Ph: (860) 236-1218 | Peter Pegolo, OD 612 Quaker Ln S, Suite B, West Hartford, CT 06110-1027 Ph: (860) 236-1218 |
News Archive
Men worried about prostate cancer have a new online resource, freely available, to help them assess their risk. The multi-step Prostate Cancer Risk Calculator, www.prostatecancer-riskcalculator.com*, has been created by the founders of the European Randomized Study of Screening for Prostate Cancer (ERSPC).
July 3 was the quiet afternoon that a deputy assistant Treasury secretary for tax policy announced in a blog post that the Affordable Care Act's employer mandate would be delayed one year. Something about the "complexity of the requirements." ... Even if you are a liberal and support the goals of the Affordable Care Act, there has to be an emerging sense that maybe the law's theorists missed a signal from life outside the castle walls. While they troweled brick after brick into a 2,000-page law, the rest of the world was reshaping itself into smaller, more nimble units whose defining metaphor is the 140-character Twitter message (Daniel Henninger, 7/10).
Advances in energy conservation, better materials for frontier technologies and new economic engines, and breakthroughs in understanding diseases: These are just a few of the potential discoveries, both basic and applied, to be enabled by an upgrade to the Advanced Photon Source (APS) at the U.S. Department of Energy's (DOE) Argonne National Laboratory. DOE today announced formal approval for conceptual design of the APS upgrade, the first in a series of major milestones that the project must meet under DOE's project management regimen.
Alemtuzumab, an anti-CD52 monoclonal antibody, provides a more effective treatment for individuals with relapsing‑remitting multiple sclerosis than the immunomodulating drug interferon beta 1a, but has significant side effects, show findings from a phase III trial.
Bupa has announced the launch of the first part of its new health section online at bupa-intl.com, featuring more interactive content and 50 medical factsheets for an international audience.
› Verified 7 days ago
Meghan Corkery, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 17 S Main St, West Hartford, CT 06107 Phone: 860-231-8482 Fax: 860-231-8791 | |
Dr. Michael S Cooper, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 1013 Farmington Ave, West Hartford, CT 06107 Phone: 860-233-2020 Fax: 860-236-4979 | |
Trimble Vision Services, Llc Optometrist Medicare: Medicare Enrolled Practice Location: 355 N Main St, West Hartford, CT 06117 Phone: 860-233-2668 Fax: 860-236-4293 | |
Dr. Charlene Marie Chateauneuf, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1013 Farmington Ave, West Hartford, CT 06107 Phone: 860-233-2020 Fax: 860-236-4979 | |
Crystal Vision West Hartford Llc. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 64 Raymond Rd, Suite170, West Hartford, CT 06107 Phone: 860-442-0380 | |
Optometric Specialty Group Limited Liability Company Optometrist Medicare: Medicare Enrolled Practice Location: 77 S Main St, West Hartford, CT 06107 Phone: 860-236-1218 |